AI assistant
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2017
Jul 6, 2017
31049_dirs_2017-07-05_11c45166-db80-45ca-a0fd-31eeb696a260.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2017-06-30
Reporting Person: EDELMAN RICHARD W (See Footnote (1))
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | Common Stock, No Par Value | M | 20000 | $9.95 | Acquired | 35000 | Direct |
| 2017-06-30 | Common Stock, No Par Value | S | 20000 | $37.619 | Disposed | 15000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | Non-qualified stock options (right to buy) | $9.95 | M | 20000 | Disposed | 2020-05-22 | Common Stock (20000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $13.75 | 2018-08-11 | Common Stock (20000) | 20000 | Direct |
| Non-qualified stock options (right to buy) | $12.91 | 2019-05-23 | Common Stock (20000) | 20000 | Direct |
| Non-qualified stock options (right to buy) | $13.99 | 2021-06-11 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $20.27 | 2022-05-22 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $18.80 | 2023-05-26 | Common Stock (25000) | 25000 | Direct |
Footnotes
F1: The reporting person ceased to be a director of the Issuer on May 24, 2017.
F2: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.53 to 37.80, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3: Became exercisable in equal annual installments of 20% commencing 08/11/2012.
F4: Became exercisable in equal annual installments of 20% commencing 05/23/2013.
F5: Became exercisable in equal annual installments of 20% commencing 05/22/2014. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
F6: Became exercisable in equal annual installments of 20% commencing 06/11/2015. Installments scheduled for vesting after 6/11/2017 will not be exercisable.
F7: Became exercisable in equal annual installments of 20% commencing 05/22/2016. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
F8: Became exercisable in equal annual installments of 20% commencing 05/26/2017. Installments scheduled for vesting after 5/26/2017 will not be exercisable.